SANUWAVE director granted 3,208 stock options

SANUWAVE Health director Gregory Matthew Bazar received a grant of stock options covering 3,208 shares of Common Stock.

Accepted by SEC EDGAR 04/02/2026 - 05:07 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

SANUWAVE Health director Gregory Matthew Bazar received a grant of stock options covering 3,208 shares of Common Stock. The options have an exercise price of $17.29 per share and were fully vested on the grant date.

The options expire on March 31, 2031, and give him the right to buy up to 3,208 shares if exercised.

Insider Trade Summary

Grant/Award: 3,208 shares

Grant/Award 1 txn

Insider Bazar Gregory Matthew

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	3,208	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 3,208 contracts (Direct)

Holdings Before and After: Stock Option (right to buy), 0 to 3,208 contracts (Direct)

Footnotes (1)

1. F1. Options were fully vested at the grant date.

Key Figures

Options granted: 3,208 options Exercise price: $17.29 per share Underlying shares: 3,208 shares +2 more

5 metrics

Options granted 3,208 options Stock Option (right to buy) granted to director

Exercise price $17.29 per share Conversion or exercise price of granted options

Underlying shares 3,208 shares Common Stock underlying the stock options

Expiration date March 31, 2031 Option expiration for the 3,208 granted options

Post-grant option holdings 3,208 options Total derivative securities following this transaction

Key Terms

Stock Option (right to buy), Grant, award, or other acquisition, Common Stock, fully vested

4 terms

Stock Option (right to buy) financial

"security_title: "Stock Option (right to buy)""

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Common Stock financial

"underlying_security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

fully vested financial

""Options were fully vested at the grant date.""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the SANUWAVE (SNVW) Form 4 filing report for Gregory Matthew Bazar?

The Form 4 reports that director Gregory Matthew Bazar received a grant of 3,208 stock options. These options give him the right to buy SANUWAVE Health common shares at a fixed $17.29 exercise price, with all options fully vested at the grant date.

How many SANUWAVE (SNVW) stock options were granted to Gregory Matthew Bazar?

Gregory Matthew Bazar was granted 3,208 stock options. Each option represents the right to purchase one share of SANUWAVE Health common stock, giving a total potential underlying amount of 3,208 shares if all options are exercised in the future.

What is the exercise price and expiration date of Bazar’s SANUWAVE (SNVW) options?

The options have an exercise price of $17.29 per share and expire on March 31, 2031. This means Bazar can choose to buy shares at $17.29 any time before that expiration date, subject to the option terms.

Were the SANUWAVE (SNVW) options granted to Bazar subject to vesting?

The options granted to Bazar were fully vested at the grant date. This means he did not need to wait for future vesting milestones and immediately held the full right to exercise all 3,208 options, within the stated expiration period.

Did Gregory Matthew Bazar buy or sell SANUWAVE (SNVW) common stock in this Form 4?

The filing shows a grant of stock options, not an open-market stock purchase or sale. Bazar acquired derivative securities (options) with an exercise price of $17.29, which may later be exercised to buy common shares, but no immediate stock trade occurred.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bazar Gregory Matthew

(Last) (First) (Middle)

9600 W. 76TH STREET

SUITE 118

(Street)

EDEN PRAIRIE MINNESOTA 55344

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SANUWAVE Health, Inc. [ SNVW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$17.29	03/31/2026		A		3,208		(1)	03/31/2031	Common Stock	3,208	$0	3,208	D

Explanation of Responses:

1. Options were fully vested at the grant date.

	/s/ Griffin D. Foster, Attorney-in-Fact for Gregory Bazar	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)